Radius

1 stories · following the connections

Business

Radius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection

By Nasdaq OMXMar 12, 2018, 8:30 PM UTC